How much is Angitia Biopharmaceuticals worth in 2026?

Angitia Biopharmaceuticals has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Angitia Biopharmaceuticals raised?

Angitia Biopharmaceuticals has raised $290.0M in total funding across 1 funding rounds.

Angitia Biopharmaceuticals

Drug DiscoveryWebsite

Angitia Biopharmaceuticals valuation and funding history | Last updated: December 3, 2024 | 1 funding rounds

Current Valuation

N/A

As of December 3, 2024

Total Funding Raised

$290.0M

Across 1 round

Last Round

Later Stage VC

$120.0M

Last Funding

Dec 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 5, 2026	Later Stage VC (Series D)	$130.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Angitia Biopharmaceuticals is currently valued at N/A as of December 3, 2024. The company has raised a total of $290.0M in funding across 1 funding round.

Track Angitia Biopharmaceuticals Valuation Updates

Get notified when Angitia Biopharmaceuticals raises new funding or valuation changes

Explore More Data

Detailed analysis for Angitia Biopharmaceuticals

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Angitia Biopharmaceuticals's valuation history, funding rounds, and growth metrics.

No credit card required

What is Angitia Biopharmaceuticals Worth in 2026?

Angitia Biopharmaceuticals is a leading private company in the Drug Discovery sector. Track Angitia Biopharmaceuticals's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Angitia Biopharmaceuticals Valuation is Determined

Private company valuations like Angitia Biopharmaceuticals's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.